Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-03 · accession 0001765581-22-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-09 | 2022-03-03 | JAZZ | Tovey Christopher J. | EVP, COO | A - Grant | $0.00 | +7,820 | 16.9K | +86% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-03 | A | A | 7,820 | $0.00 | 16,936 | D | — | — |